<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD 2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
	<front>
		<journal-meta>
			<journal-id journal-id-type="nlm-ta">J Proteomics Bioinform</journal-id>
			<journal-id journal-id-type="publisher-id">opg</journal-id>						
			<journal-title>Journal of Proteomics &amp; Bioinformatics</journal-title>			 
			<issn pub-type="epub">0974-276X</issn>
			<publisher>
				<publisher-name>OMICS Publishing Group</publisher-name>
				<publisher-loc>India, USA</publisher-loc>
			</publisher>
		</journal-meta>
		<article-meta>			
			<article-id pub-id-type="publisher-id">000063</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Research Article</subject>
				</subj-group>
				<subj-group subj-group-type="Discipline">
					<subject>Biochemistry</subject>
				</subj-group>
				<subj-group subj-group-type="System Taxonomy">
					<subject>Proteomics</subject>
					<subject>Bioinformatics</subject>
					<subject>Genomics</subject>
					<subject>Transcriptomics</subject>
					<subject>Biomarkers</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Integrated Bioinformatics for Radiation-Induced Pathway Analysis from Proteomics and Microarray Data</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<name>
						<surname>Hu</surname>
						<given-names>Zhang-Zhi</given-names>
					</name>					
					<xref ref-type="aff" rid="a1">1</xref>
					<xref ref-type="corresp" rid="cor1">&ast;</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Huang</surname>
						<given-names>Hongzhan</given-names>
					</name>
					<xref ref-type="aff" rid="a1">1</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Cheema</surname>
						<given-names>Amrita</given-names>
					</name>
					<xref ref-type="aff" rid="a2">2</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Jung</surname>
						<given-names>Mira</given-names>
					</name>
					<xref ref-type="aff" rid="a3">3</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Dritschilo</surname>
						<given-names>Anatoly</given-names>
					</name>
					<xref ref-type="aff" rid="a3">3</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Wu</surname>
						<given-names>Cathy H.</given-names>
					</name>
					<xref ref-type="aff" rid="a1">1</xref>										
				</contrib>
			</contrib-group>
			<aff id="a1"><label>1</label>Department of Biochemistry and Molecular &amp; Cellular Biology</aff>
			<aff id="a2"><label>2</label>Proteomics and Metabolomics Shared Resource</aff>
			<aff id="a3"><label>3</label>Department of Radiation Medicine, Lombardi Comprehensive Cancer Center Georgetown University Medical Center, Washington, DC 20007, USA</aff>
			<author-notes>
				<corresp id="cor1">&ast; To whom correspondence should be addressed: Zhang-Zhi Hu, MD, Research Associate Professor and Associate Team Lead, Protein Information Resource (PIR), Department of Biochemistry and Molecular &amp; Cellular Biology, Georgetown University, Medical Center 3300 Whitehaven Street,NW, Suite 1200 Washington, D.C. 20007, Phone: (202) 687-1255; Fax: (202) 687-1662; E-mail: <email>zh9@georgetown.edu</email></corresp>
			</author-notes>
			<pub-date pub-type="collection">
			     <month>05</month>
				 <year>2008</year>
			</pub-date>
			<pub-date pub-type="epub">
				<day>24</day>
				<month>05</month>
				<year>2008</year>
			</pub-date>			
			<volume>1</volume>
			<issue>2</issue>
			<fpage>047</fpage>
			<lpage>060</lpage>
			<history>
			<date date-type="received">
			     <day>24</day>
				 <month>05</month>
				 <year>2008</year>
			</date>
			<date date-type="accepted">
			      <day>24</day>
				  <month>05</month>
				  <year>2008</year>
			</date>
			</history>
			<permissions>			
			<copyright-statement><bold>Copyright:</bold> &copy; 2008 Zhang ZH, etal.</copyright-statement>
			<copyright-year>2008</copyright-year>
			<license license-type="open access">
			<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
			 </license>
			 </permissions>					
			<abstract>
				<p>Functional analysis and interpretation of large-scale proteomics and gene expression data require effective use of bioinformatics tools and public knowledge resources coupled with expert-guided examination. An integrated bioinformatics approach was used to analyze cellular pathways in response to ionizing radiation. ATM, or mutated in ataxia-telangiectasia, a serine-threonine protein kinase, plays critical roles in radiation responses, including cell cycle arrest and DNA repair. We analyzed radiation responsive pathways based on 2D-gel/MS proteomics and microarray gene expression data from fibroblasts expressing wild type or mutant ATM gene. The analysis showed that metabolism was significantly affected by radiation in an ATM dependent manner. In particular, purine metabolic pathways were differentially changed in the two cell lines. The expression of ribonucleoside- diphosphate reductase subunit M2 (RRM2) was increased in ATM-wild type cells at both mRNA and protein levels, but no changes were detected in ATM-mutated cells. Increased expression of p53 was observed 30min after irradiation of the ATM-wild type cells. These results suggest that RRM2 is a downstream target of the ATM-p53 pathway that mediates radiation-induced DNA repair. We demonstrated that the integrated bioinformatics approach facilitated pathway analysis, hypothesis generation and target gene/protein identification.</p>
			</abstract>
			<kwd-group>
				<kwd>Bioinformatics</kwd>
				<kwd>proteomics</kwd>
				<kwd>radiation</kwd>
				<kwd>purine metabolism</kwd>
				<kwd>DNA repair</kwd>
				<kwd>pathway and network</kwd>
			</kwd-group>
			<custom-meta-wrap>
				<custom-meta>
					<meta-name>citation</meta-name>
					<meta-value>Zhang ZH, Hongzhan H, Amrita C, Mira J, Anatoly D, etal. (2008)Integrated Bioinformatics for Radiation-Induced Pathway Analysis from Proteomics and Microarray Data.</meta-value>
				</custom-meta>
			</custom-meta-wrap>
		</article-meta>
	</front>
	<body>		 
		 <sec id="s1">
		 	<title>Introduction</title>
				<p>The last decade has seen a rapid expansion of genomics, transcriptomics, proteomics, and other omics studies applied to all areas of biomedical research. High-throughput technologies such as DNA microarray and mass spectrometry (MS)-based proteomics allow generation of large amounts of data from a single experiment. However, high-throughput data are generally of high variation, low reproducibility, noisy (<xref ref-type="bibr" rid="r20">von Mering and Bork, 2002</xref>), thus analysis and interpretation of the omics data remain challenging and require effective bioinformatics approaches. Biological interpretation of high-throughput data for forming hypotheses and for guiding experimental validation is typically a downstream process of the omics workflow after the high-throughput raw data are processed for functional analysis. At the core of functional interpretation of omics data is the knowledge (such as annotations and literature data) provided to the biological objects, being genes, mRNAs, or proteins from various molecular databases. Meanwhile bioinformatics tools have been developed for analyzing and interpreting the large lists of genes or proteins, such as DAVID (<xref ref-type="bibr" rid="r8">Huang et al., 2007</xref>), BABELOMICS (<xref ref-type="bibr" rid="r2">Al- Shahrour et al., 2005</xref>), Ingenuity <ext-link ext-link-type="uri" xlink:href="www.ingenuity.com/">http://www.ingenuity.com/</ext-link> and GeneGO (<xref ref-type="bibr" rid="r5">Ekins et al., 2007</xref>) for function and pathway analysis of large-scale data.</p>
				<p>While bioinformatics tools have greatly assisted data analysis, a careful review of the major steps and flow of data in a typical high-throughput analysis reveals gaps that need to be addressed. One issue is the lack of standardization when dealing with a large list of proteins or genes annotated in different sources. For example, different protein IDs/names may be used for the same protein in different sources, even different versions of the same database may result in different IDs if the database identifier is not stable. The lack of standards presents a continuing challenge for integrating annotations from heterogeneous databases. Consequently, expression analysis is often carried out in an ad hoc manner, with a fragmented and inefficient use of rich annotations available in various resources. In addition, the effectiveness of the bioinformatics analysis system often relies on the amount and the type of knowledge available for genes and proteins annotated in the databases. To provide effective protein or gene ID mapping and comprehensive annotations for the largescale data analysis, we integrated two databases, UniProt (<xref ref-type="bibr" rid="r26">UniProt Consortium, 2008</xref>) and iProClass (<xref ref-type="bibr" rid="r28">Wu et al., 2004</xref>), into an integrated bioinformatics analysis system, iProXpress recently developed at the Protein Information Resource (PIR) (<xref ref-type="bibr" rid="r9">Huang et al., 2007</xref>). UniProt is a central international repository of protein sequences and functional information and provides the most comprehensive annotations for all proteins. iProClass database is a protein knowledge base providing value-added annotations integrated from over 90 molecular biology databases. iProClass coupled with UniProtKB became a data powerhouse of the iProXpress system, serving as a basic infrastructure for the omics data mapping and as a knowledge source for data analysis and interpretation.</p>
				<p>In this paper, we describe an integrated bioinformatics approach for the gene expression and proteomics studies of human fibroblasts derived from patients with ataxia teleangiectasis (AT) who are sensitive to ionizing radiation-induced DNA damage. Radiation induces a myriad of cellular responses, including genotoxic stress signaling, cell cycle arrest, activation of a complex DNA repair machinery, and metabolic changes (<xref ref-type="bibr" rid="r27">Valerie, et al., 2007</xref>; <xref ref-type="bibr" rid="r11">Jeggo and Löbrich 2006</xref>; <xref ref-type="bibr" rid="r25">Spitz et al., 2004</xref>). ATM, or ataxia-telangiectasia mutated was first identified in AT patients in 1995 (<xref ref-type="bibr" rid="r24">Savitsky et al., 1995</xref>). ATM plays critical roles in radiation- induced responses (<xref ref-type="bibr" rid="r14">Kastan et al., 2001</xref>; <xref ref-type="bibr" rid="r17">Kurz and Lees- Miller, 2004</xref>), and has been identified as a potential target for novel radiosensitizers (<xref ref-type="bibr" rid="r23">Sarkaria and Eshleman, 2001</xref>, <xref ref-type="bibr" rid="r1">Ahmed and Li 2007</xref>). For example, small molecule inhibitors of ATM or downstream signaling molecules (<xref ref-type="bibr" rid="r15">Kim et al., 1999</xref>; <xref ref-type="bibr" rid="r13">Jung and Dritschilo, 2001</xref>) may offer a strategy to sensitize tumors to the lethal effects of ionizing radiation while sparing normal tissues.</p>
				<p>To identify ATM-mediated pathways underlying cellular responses to ionizing radiation that lead to radiation resistance or sensitivity in cells, the AT-patient derived fibroblasts expressing mutated ATM genes or wild-type ATM were used as models. The two cell lines were subjected to proteomics and microarray experiments, analyzed by global expression profiling and pathway/ network analysis. We showed radiation-induced and ATMmediated major biological pathways and proposed proteins for further validation.</p>
		 </sec>
		 <sec sec-type="methods">
		 	<title>Materiala and Methods</title>
				<p>The exprimental data is available in i ProXpress for search and browsing at <ext-link ext-link-type="uri" xlink:href="www.pir.georgetownedu/cgi-bin/textsearch_iprox.pl?data=gul">http://pir.georgetownedu/cgi-bin/textsearch_iprox.pl?data=gul</ext-link>.</p>
				<sec>
					<title>Experimental Data Source</title>
						<p>The proteomics and gene expression data were obtained from radiation-treated AT5BIVA and ATCL8 cell lines. AT5BIVA was derived from human fibroblasts of ataxia teleangiectasis (AT) patient with mutated ATM (AT mutated) gene (<xref ref-type="bibr" rid="r12">Jung et al, 1995</xref>), while ATCL8 was derived by reintroducing the wild-type ATM gene into the AT5BIVA cells. The two cell lines were exposed to 10 Gy of ionizing radiation and analyzed at time intervals from 30 minutes to 24 hours. The proteomics data were obtained from two-dimensional gel electrophoresis (2D-gel) followed by MALDI-MS of the excised gel spots. The gene expression data were obtained using Affymetrix DNA microarray (U133A probe set of 14500 human genes) chip assays. The experimental procedures for cell culture and radiation treatment, 2D-gel, MALDIMS proteomics and microarray have been described elsewhere (<xref ref-type="bibr" rid="r18">Lee et al., 2001</xref>; <xref ref-type="bibr" rid="r21">Mewani et al, 2006</xref>). Protein identification from MALDI-MS was based on MASCOT search engine using UniProtKB/Swiss-Prot database. Lists of proteins were identified (with UniProtKB accession #) from differentially changed 2D-gel spots based on &gt;=2-fold changes (p-value &lt;=0.05), increased (including newly appeared spots after irradiation) or decreased (including spots only in control but disappeared after irradiation) for each time point and cell type. Lists of genes were identified (with Entrez Gene #) from differentially expressed mRNAs (increased or decreased) in microarray based on &gt;= 1.5- fold changes (p-value &lt;= 0.05).
						</p>
				</sec>
				<sec>
					<title>Data Integration and Bioinformatics Analysis</title>
						<p>We applied an integrated bioinformatics approach for the proteomics and gene expression data analysis. The iProXpress integrated protein expression analysis system <ext-link ext-link-type="uri" xlink:href="pir.georgetown.edu/iproxpress/">http://pir.georgetown.edu/iproxpress/</ext-link> was primarily used as a platform for the functional data analysis, coupled with the Ingenuity Pathway Analysis (IPA) tool for pathway and network analysis. A prototype of the iProXpress system has been applied to several previous high-throughput studies (<xref ref-type="bibr" rid="r19">Li et al., 2004</xref>; <xref ref-type="bibr" rid="r3">Chi et al., 2006</xref>, <xref ref-type="bibr" rid="r7">Hu et al., 2007</xref>). Below we briefly describe the bioinformatics analysis procedures.</p>
						<p>1) <italic>Protein mapping:</italic> Gene or protein lists were mapped to UniProtKB protein entries primarily based on gene/protein identifiers. Genes with common identifiers such as GenBank, UniGene or Entrez Gene are mapped based on the PIR ID mapping service <ext-link ext-link-type="uri" xlink:href="pir.georgetown.edu/pirwww/search/idmapping.shtml">http://pir.georgetown.edu/pirwww/search/idmapping.shtml</ext-link>. For genes with no ID match, the mapping is based on sequence comparison, or name mapping if the sequence is not available. The protein and gene lists from AT5BIVA and ATCL8 cells were integrated into the iProXpress system after protein mapping.</p>
						<p>2) <italic>Protein annotation:</italic> After protein mapping, rich annotations are described in a protein information matrix that captures salient features of proteins, such as functions and pathways, for given experimental data sets. These rich annotations are derived from comprehensive protein information that have been integrated into the UniProt and iProClass databases and from sequence analysis for homology-based inference.</p>
						<p>3) <italic>Functional profiling:</italic> The gene and protein lists were divided into experimental groups based on cell types and time course for functional profiling using various functional attributes (i.e. annotation fields of the protein information matrix). Primarily used for functional profiling were GO slims (a subset of GO with high level terms at GO hierarchy) <ext-link ext-link-type="uri" xlink:href="www.geneontology.org/GO.slims">http://www.geneontology.org/GO.slims</ext-link> and pathway information (e.g. from KEGG database).</p>
						<p>4) <italic>Pathway and network analysis:</italic> Pathway visualization was based on pathway diagrams provided in source pathway databases such as KEGG and the IPA tool. An ATM protein interaction pathway map was also used, which was curated by scientists who initially discovered the ATM gene (<xref ref-type="bibr" rid="r24">Savitsky et al., 1995</xref>) and reflects the current state of knowledge for ATM-mediated pathways available at <ext-link ext-link-type="uri" xlink:href="www.cs.tau.ac.il/~spike/images/1.png">http://www.cs.tau.ac.il/~spike/images/1.png</ext-link>. Network analysis was done using the IPA tool, which dynamically generates functional association networks based on curated literature information of protein-protein interaction, coexpression, and genetic regulation. </p>
						<p><xref ref-type="fig" rid="g1">Figure 1</xref> depicts genotypes the overview of an integrated bioinformatics approach to analyze and interpret the proteomics and gene expression data from irradiated cells with mutant or wild type ATM genotypes.</p>
				<fig id="g1">
					<label>Figure 1</label>
					<caption>
						<title>Integrated bioinformatics approach for radiation-induced function and pathway analysis from proteomics and gene expression data</title>
					</caption>
					<graphic xlink:href="JPB-01-047-g001.tif"/>
				</fig>
				<p><xref ref-type="fig" rid="g2">Figure 2</xref> shows the iProXpress web interface for searching, browsing, and profiling the experimental groups of different cell types, time courses, and protein or mRNA level changes. The interactive graphical user interface provided several functionalities for data analysis, such as selecting data groups, browsing the proteins and associated annotations, and expression profiling using GO slims and pathways.</p>
				<fig id="g2">
					<label>Figure 2</label>
					<caption>
						<title>iProXpress web interface for browsing and profiling proteomics and microarray data.</title>
						<p>1) Selected experimental groups can be chosen from the pull down menu.  2) Boolean operations can be used to query the data, such as&ldquo;get all  proteins identified from proteomics (A_8_30m*) OR microarray (B_8_30m*)  in ATCL8 cell at 30 minutes.&rdquo; 3) The &ldquo;protein information matrix&rdquo;  displays protein list from the selected groups, and provides  annotations integrated from over 90 sources. 4) The&ldquo;Display Option&rdquo;  allows selection of desired fields for display. 5) For the given list  of proteins, the interface provides functional profiling&ldquo;buttons&rdquo; to  show profiles in GO slim (molecular function, cellular component, and  biological process) or KEGG pathways. 6) The interface also provides  protein sequence analysis tools listed such as BLAST, FASTA and  sequence alignment. 7) An example of GO biological process profile. 8)  Comparative profiling across selected data groups based on given GO  categories.</p>
					</caption>
					<graphic xlink:href="JPB-01-047-g002.tif"/>
				</fig>
				</sec>
		 </sec>
		 <sec id="s3">
		 	<title>Results</title>
			<sec>
				<title>Radiation-Induced Changes in Expression Profiles</title>
					<p>The 2D-gel/MS proteomics and DNA microarray data generated from radiation-treated AT5BIVA and ATCL8 cells are summarized in <xref ref-type="table" rid="t1">Table 1</xref>, which shows total numbers of UniProt protein entries mapped from proteomics and gene expression data. Most up-regulated proteins were observed at 3hr post-irradiation in both AT5BIVA and ATCL8 cells, and with many more up-regulated in ATCL8 than in AT5BIVA cells. In contrast, most downregulated proteins were seen at 30min in ATCL8 and at 24hr in AT5BIVA cells. At gene expression level, prominent responses to radiation at early time in ATCL8 cells were observed, for example, three times as many mRNAs were up-regulated at 30min in ATCL8 (33) as in AT5BIVA (11) cells, while up-regulation of most genes was only seen 1hr after radiation in AT5BIVA cells. These differences showed that ATCL8 was more radiation-responsive at both protein and mRNA levels at earlier time than the ATM-mutated AT5BIVA cells. Compared to AT5BIVA, ATCL8 cells were shown to quickly respond to irradiation at 30min by increasing more gene expressions and by decreasing the amounts and/or activities (presumably modification states) of more proteins, followed by increasing more at 3hr.</p>
					<p>The profiling of the differentially changed proteins or genes from irradiated cells based on GO slims and the KEGG pathways provided global views of functional changes in these cells. <xref ref-type="table" rid="t2">Table 2</xref> shows the major GO biological process categories of radiation induced protein changes. The total changed proteins (combined up- and down-) in the two cell lines generally showed similar profiles among top categories of GO biological processes. However, profiles based on up- or down-regulated proteins showed clear differences between the two cell lines. For example, in AT5BIVA cells, a higher percentage of proteins involved in cell cycle was down-regulated (8.3%) than up-regulated (4.8%), and more were up-regulated than down-regulated in RNA <italic>metabolism, transcription,</italic> and <italic>protein biosynthesis</italic>. In ATCL8 cells, a higher percentage of proteins were up-regulated in <italic>signal transduction</italic> and <italic>protein modification</italic>, while more were down-regulated in <italic>protein biosynthesis.</italic></p>
					<p>When profiling is performed using KEGG pathways for the total changed proteins, differences were observed in the percentages of proteins involved in <italic>purine metabolism, glycolysis/gluconeo-genesis, pyrimidine metabolism, and glutamate metabolism</italic> in the two cell lines. Pathway profiling based on the up- or downregulated proteins resulted in more differences between the AT5BIVA and ATCL8 cells. For example, higher percentages of down-regulated proteins in <italic>purine metabolism</italic> and of up-regulated proteins in <italic>starch and sucrose metabolism</italic> and <italic>folate biosynthesis</italic> were observed in AT5BIVA cells. Also consistent with GO process profiles, more cell cycle proteins were seen downregulated in AT5BIVA while more were up-regulated in ATCL8 cells. Overall, metabolic pathways were clearly affected, and purine metabolism was the most affected pathway in irradiated AT5BIVA and ATCL8 cells based on the expression profiling using iProXpress as well as from the Ingenuity pathway profiles (not shown).</p>
			</sec>
			<sec>
				<title>Biological Pathways and Signaling Proteins in Response to Radiation</title>
					<p>Although the general profiles in <xref ref-type="table" rid="t2">Table 2</xref> provided global views of major functional changes in the two cell lines without regard to specific time points, profiles based on more specific or focused data groups, such as at certain time points, offered more biological insights. We selected a proteomics data set at 3hr from both AT5BIVA and ATCL8 cells and a microarray data set at 30min from ATCL8 only for further analysis, when most differentially changed protein or gene expressions were observed or most upregulation of proteins or genes occurred (<xref ref-type="table" rid="t1">Table 1</xref>). The comparative pathways profiling of four data groups representing the upand down-regulated proteins from AT5BIVA and ATCL8 cells at 3hr post-irradiation showed that purine metabolism is the most predominant pathway with 10 differentially expressed proteins, and major differences exist between the four data groups (<xref ref-type="fig" rid="g3">Figure 3</xref>). </p>				
				
				<fig id="g3">
					<label>Figure 3</label>
					<caption>
						<title>Comparative pathway profiling of proteomics data from AT5BIVA and ATCL8 cells at 3hr post-irradiation.</title>
							<p>The four specific groups represent up- and down-regulated proteins from each cell line at 3hr after irradiation (&ldquo;A_5_3h_decrease&rdquo; and&ldquo;A_5_3h_increase&rdquo; from AT5BIVA, and &ldquo;A_8_3h_decrease&rdquo; and &ldquo;A_8_3h_increase&rdquo; from ATCL8 cells). The displayed numbers of proteins in given categories and data groups are linked to the protein information matrix for these proteins. Purine metabolism is highlighted with the dotted box to indicate that the most number of differentially changed proteins fall into this pathway. This comparative profile is a partial displays of the 69 KEGG metabolic pathways for the data sets (most of the rest have a total of &lt;= 5 proteins for each pathway).</p>
					</caption>
					<graphic xlink:href="JPB-01-047-g003.tif"/>
				</fig>
				<p><xref ref-type="table" rid="t3">Table 3</xref> lists proteins of purine metabolism from all time points (30min to 24hr) in AT5BIVA and ATCL8 cells. Most enzyme changes in this pathway occurred at 3hr in both cell lines, and those changed at other time points were mostly down-regulated in both cells. Strikingly, while most changed enzymes were downregulated at 3hr in AT5BIVA cells, all changed enzymes were up-regulated at 3hr in ATCL8 cells. Two enzymes with opposite changes were identifiet from the two cell lines, adenylate kinase 2 (up in ATCl8 and down in AT5Cl8 at 30min), and IMP dehdrogenase 2 (up in ATCl8 at 3hr and down in AT5BIVA at 24hr).</p>
					<p><xref ref-type="fig" rid="g4">Figure 4</xref> shows a diagram of the purine metabolism pathway with differentially expressed enzymes listed in <xref ref-type="table" rid="t3">Table 3</xref> superimposed onto the pathway map. Interestingly, most of these enzymes are located at the biochemical steps surrounding the ADP/ATP or GDP/GTP synthesis. For enzymes involved in these steps, most were down-regulated in AT5BIVA cells, while most were up-regulated in ATCL8. This strongly suggests that the ATCL8 cells were able to respond to irradiation by increasing the amount or activities of nucleotide synthesis enzymes to prepare for increased DNA synthesis and repair.</p>
				<fig id="g4">
					<label>Figure 4</label>
					<caption>
						<title>Differentially expressed enzymes in purine metabolism identified from irradiated AT5BIVA and ATCL8 cells.</title>
							<p>Enzyme Commission numbers (EC#, e.g. 1.17.4.1) are used to represent enzymes in metabolism. Highlighted in green background are known human enzymes annotated in the KEGG database. Differentially expressed enzymes in purine metabolism (<xref ref-type="table" rid="t3">Table 3</xref>) are superimposed onto this pathway diagram: blue-boxed are enzymes changed in AT5BIVA cells, red-boxed those in ATCL8 cells, and pinkboxed those from both cells. Areas circled with broken lines highlight closely related biochemical steps surrounding ADP/ATP (left) or GDP/GTP (right) metabolisms, which include most of these differentially expressed enzymes from either cell type.</p>
					</caption>
					<graphic xlink:href="JPB-01-047-g004.tif"/>
				</fig>	
				<p>Because of the relatively low numbers of differentially expressed genes from the microarray experiment, expressing profiling using GO or KEGG pathways was usually not revealing for most of the experimental groups (<xref ref-type="table" rid="t1">Table 1</xref>). Instead we focused on the differentially expressed genes from ATCL8 cells at 30min postirradiation, when more genes were differentially expressed in ATCL8 than in AT5BIVA cells, and most up-regulated genes in ATCL8 occurred. <xref ref-type="table" rid="t4">Table 4</xref> lists gene products from the top 3 GO biological process categories, signal transduction, protein modification, and transcription, from the microarray experiment. Among them, p53, BRCA1 and HDAC1 were all up-regulated at 30min in ATCL8 cells and are also well-known to be involved in DNA repair and cell cycle control.</p>
				<p>Furthermore, despite the low numbers of differentially expressed genes from microarray experiment, it was interesting to correlate these genes with differentially changed proteins from proteomics data. A total of 103 proteins (UniProt entries) from AT5BIVA and 131 from ATCL8 cells were mapped from from the microarray data of both AT5BIVA and ATCL8 cells (<xref ref-type="table" rid="t1">Table 1</xref>).shows the common protein set of 13 proteins, namely the overlapping genes/proteins between the proteomics and microarray data, 10 were from ATCL8 and 3 from AT5BIVA cells.</p>
				<p>Interestingly, from above proteomics and microarray data RRM2 was shown to be increased at both mRNA and protein levels in ATCL8 cells, with mRNA level increased at 30min, and protein level increased at 1hr and 3hr (<xref ref-type="table" rid="t3">Table 3</xref> and <xref ref-type="fig" rid="g4">Figure 4</xref>).</p>	
			</sec>
			<sec>
				<title>RRM2-Associated Functional Networks and Pathways </title>
					<p>A critical rate-limiting enzyme in DNA synthesis, RRM2 expression increased in ATCL8 cells at 1hr and 3hr after irradiation, while no changes were detected in AT5BIVA cells. Since RRM2 is involved in DNA repair, we wanted to examine the functional association networks involving RRM2 in the context of current proteomic and gene expression data.</p>
					<p><xref ref-type="fig" rid="g5">Figure 5</xref> shows the network in which RRM2 is connected with several major DNA repair and cell cycle proteins, including HDAC1, p53, BRCA1, and CDKN2A, directly or indirectly. Except for CDKN2A, a negative regulator of cell cycle progression, the other three proteins were all differentially regulated in ATCL8 cells, suggesting that RRM2 play an important role in radiation-induced and ATM-mediated DNA repair processes and cell cycle control.</p>
					<p>Since AT5BIVA and ATCL8 cell lines were specifically designed as models for examining ATM-mediated pathways, we used an ATM protein interaction pathway map to examine changed proteins or genes from proteomics and gene expression data. This pathway map (<xref ref-type="fig" rid="g6">Figure 6</xref>, left) shows that two proteins directly interacted with and activated by ATM are p53 and BRCA1, which were up-regulated in ATCL8 cells. Based on the expression data and the network analysis, we hypothesize that RRM2 is involved in radiation induced ATM-p53-mediated DNA repair pathway in the ATCL8 cells (<xref ref-type="fig" rid="g6">Figure 6</xref>, right). RRM2 directly binds p53 and upon irradiation dimerizes with RRM2 to form the ribonucleotide reductase (RR) holoenzyme complex. Increased RR activity will result in an increase in the pool of deoxyribonucleotide precursors for DNA synthesis which is required for DNA repair in response to radiation damage.</p>
			 </sec>			
		</sec>
		<sec id="s4">
			<title>Discussion</title>
				<p>In this study we used an integrated bioinformatics approach (<xref ref-type="fig" rid="g1">Figure 1</xref>) to analyze and interpret the proteomics and gene expression data from radiation treated cells with mutant or wild type ATM genotypes. The iProXpress system provides a protein-centric data integration for functional analysis and allows direct comparison of different molecules (mRNA vs. protein) from same samples under study. As functional understanding of the omics data is underpinned by the current knowledge annotated in databases for given lists of genes or proteins from high throughput experiments, it is crucial to maximize the use of known knowledge from heterogeneous databases and resources. The iProXpress system uses both iProClass and UniProtKB databases for data mapping, data analysis and interpretation, and also takes advantage of the extensive informatics infrastructure at PIR, e.g. the Text Search engine for data browsing and searching. One of the most useful features of the iProXpress system is to allow comparison of functional profiles across multiple data sets or groups obtained from different issue/cell types and time points, or from different omics experiments. In particular, while differential profiles with GO slim or pathway terms may not be evident when generated from combined data groups, profiles from more specific groups may reveal clearer differences. For example, purine metabolism became evident when examining individual time points from both AT5BIVA and ATCL8 cells.<xref ref-type="table" rid="t5">Table 5</xref></p>
			<p>While existing annotations from databases are critical for the omics analysis, the knowledge base is still limited. GO has become a common standard for annotation and functional analysis, but currently only about half of all human genes/proteins are annotated with GO terms, and even less with experimentally validated and manually annotated GO functions. Compared to GO profiling, pathway and network mapping provide more biological insight, however, an estimated  10% of human genes/ proteins have been annotated with biological pathways in databases. Therefore, as part of the integrated bioinformatics approach, expert-guided analysis should be coupled with review of scientific literature for functional interpretation of the large scale omics data and for formulation of scientific hypothesis.</p>
				<p>The expression profiling and pathway/network analyses have shown that enzymes of purine metabolisms, especially surrounding steps of the ADP/ATP and GDP/GTP synthesis, were differentially affected in irradiated AT5BIVA and ATCL8 cells. RRM2 is a small subunit of the RR complex that is well known for its role in DNA synthesis. RR is the only enzyme responsible for the reduction of ribonucleotides to their corresponding deoxyribonucleotides, providing a balanced supply of precursors for DNA synthesis and repair. It has been shown that an increase in RRM2 protein levels and RR activity in human nasopharyngeal cancer cells results in ionizing radiation resistance, which appears mediated by enhanced ionizing radiation damage repair during G2 phase of the cell cycle. However, overexpression of the large subunit, RRM1, of RR in these cells did not affect RR activity or ionizing radiation response (<xref ref-type="bibr" rid="r16">Kuo et al., 2003</xref>). RRM2 over expression is also associated with gemcitabine chemoresistance in pancreatic adenocarcinoma cells, and that suppression of RRM2 expression using RNA interference enhances gemcitabine-induced cytotoxicity in vitro (<xref ref-type="bibr" rid="r4">Duxbury et al., 2004</xref>). Human RRM2 has been shown to be a target of p53 through direct protein-protein interaction that leads to the nuclear accumulation of RR subunits after UV exposure (<xref ref-type="bibr" rid="r29">Xue et al., 2003</xref>), and inhibition of RRM2 by hydroxyurea results in increased sensitivity to UV irradiation in prostate cancer (PC3) cells (<xref ref-type="bibr" rid="r32">Zhou et al., 2003</xref>). Our results suggest that RRM2 is involved in the ATM- and p53-mediated signaling pathway leading to DNA repair in response to radiation in ATCL8 cells, while the ATM-mutated AT5BIVA cells became more sensitive to radiation possibly due to the impaired activation of RRM2 expression.</p>
			<fig id="g5">
					<label>Figure 5</label>
					<caption>
						<title>Functional networks showing RRM2 connected to other major DNA repair and cell cycle proteins, such as p53, BRCA1, HDAC1.</title>
							<p>Networks were generated using the Ingenuity tool for both proteomic and microarray data from this study. The networks shown were merged from three subnetworks, one containing RRM2 and HDAC1, one with p53, and the third with BRCA1. The protein or gene nodes encircled with orange line are those differentially expressed from this study. The lines (edges) connecting nodes are associations for proteins or genes based on the Ingenuity knowledgebase, which encompasses interaction, binding, activation, inhibition, etc. Gray lines are protein/gene associations within the initial subnetworks, while orange lines depict relations to linking the subnetworks. Solid lines are for direct and broken ones for indirect associations.</p>
					</caption>
					<graphic xlink:href="JPB-01-047-g005.tif"/>
				</fig>	
				<p>Most of proteins in this study were derived from the 2D-gel/MS experiment, and not all identified proteins from given 2D-gel spots were responsible for the observed changes. We used this integrated bioinformatics to help rational selection of candidate proteins for validation. Based on common pathways (e.g. purine metabolism) and their differential expression patterns, we can preferentially select those proteins commonly associated with a pathway over those not associated with the pathway for validation. Indeed, the enzyme RRM2, identified from a spot with 40 identified proteins at 3hr and a spot with 12 identifications at 1hr in ATCl8 cells (not shown), was actually one that was most likely to have changed, also consistent with the finding that RRM2 mRNA was up-regulated at 1hr in the same cells.</p>
				<fig id="g6">
					<label>Figure 6</label>
					<caption>
						<title>RRM2 is involved in radiation-induced ATM-p53-mediated DNA repair pathway</title>
							<p>The ATM pathway map on the left was based on http://www.cs.tau.ac.il/~spike/images/1.png. Shown in the map are two proteins, p53 (TP53) and BRCA1 (highlighted in red boxes), directly interact with ATM (green box) as its downstream signaling proteins. The right diagram depicts the ATM-p53 mediated and radiation-induced DNA repair pathway involving RRM2. The RRM2’s connections to p53 and HDAC1 were derived from the network analysis and were consistent with the expression data in this study. Both BRCA1 and HDAC1 are known to be involved in DNA repair. The interactions between p53 and RRM2 proteins and between HDAC1 and RRM2 gene promoter have been reported in literature. The red colored proteins are observed as differentially expressed in response to radiation from this study. Solid arrows indicate direct binding, and dotted ones indicate multi-step processes.</p>
					</caption>
					<graphic xlink:href="JPB-01-047-g006.tif"/>
				</fig>
				<p>It was noted that the intersection between changed proteins and genes from the proteomics and gene expression data in this study was small. The lack of direct correlation between changes in proteins and genes from gene expression and proteomics experiments has been previously observed (<xref ref-type="bibr" rid="r10">Jansen et al., 2002</xref>; <xref ref-type="bibr" rid="r6">Hewick et al., 2003</xref>). This is due in part to the experimental artifacts and in part to differential post-transcriptional or post-translational regulation of genes or proteins. For example, an increased or new 2D-gel spot may result from increased protein phosphorylation without corresponding mRNA changes. Constructing gene regulatory networks may potentially help identify correlations between proteomics and gene expression data when direct correlation between the two is not apparent (<xref ref-type="bibr" rid="r22">Perco et al., 2005</xref>).</p>
				<p>Besides identifying RRM2 as a potential downstream target of the ATM-p53-mediated pathway for DNA repair in response to radiation, other enzymes in purine metabolism and several other metabolic pathways, such as AK2, IMPDH, and NDK, were differentially expressed as well in the two cell lines. Interestingly, three forms of NDKs (nucleoside diphosphate kinase) were observed to be down-regulated in AT5BIVA cells. NDKs have recently been found to have DNA binding and exonuclease activities (<xref ref-type="bibr" rid="r31">Yoon et al., 2005</xref>). It is not clear however whether this is related to the reduced DNA damage repair in ATM mutated cells. Their roles and significance of these metabolic enzymes in the ATM-mediated pathways and in radiation responses remain to be further examined. Currently we are extending this study by applying metabolomics measurement to the two cell lines after irradiation, aiming to identify changes in metabolites in response to irradiation and the anticipated differential patterns in wildtype ATM vs. mutant ATM-expressing cells. Our current proteomics and gene expression data will provide a valuable reference for future analysis and interpretation of radiation damage- induced metabolites. We envision that integration and correlation of proteomics, functional genomics and metabolomics data generated from the same experimental system will provide new biological insight.</p>		
				<p>In conclusion, we have demonstrated an integrated bioinformatics approach that includes expert-guided examination of data to define radiation-induced and ATM-mediated pathways in cell models with wild-type or mutant ATM genotype. We have shown that purine metabolic pathways were differentially affected in response to radiation, and that RRM 2 was up-regulated only in ATM-wild type but not in ATM-mutated cells. We hypothesize that in this cell model, ionizing radiation activates ATM-p53- mediated pathway that directly targets RRM2 and leads to DNA damage repair, thus increasing radiation resistance in the ATCL8 cells.</p>
		</sec>		 
	</body>
	<back>
		<ack>
			<p>This work is supported in part by NIH/NCI grant (P01CA074175). The bioinformatics infrastructure for this study was supported in part by NIH grant U01-HG02712.</p>
		</ack>
		<ref-list>
			<title>References</title>
					<ref id="r1">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Ahmed</surname>
								<given-names>KM</given-names>
							</name>
							<name>
								<surname>Li</surname>
								<given-names>JJ</given-names>
							</name>
							</person-group>
							<year>2007</year>
							<article-title>ATM-NF-kappaB connection as a target for tumor radiosensitization</article-title>
							<source>Curr Cancer Drug Targets</source>
							<volume>7</volume>
							<fpage>335</fpage>
							<lpage>342</lpage>
					</citation>
					</ref>
					<ref id="r2">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Al-Shahrour</surname>
								<given-names>F</given-names>
							</name>
							<name>
								<surname>Minguez</surname>
								<given-names>P</given-names>
							</name>
							<name>
								<surname>Vaquerizas</surname>
								<given-names>JM</given-names>
							</name>
							<name>
								<surname>Conde</surname>
								<given-names>L</given-names>
							</name>
							<name>
								<surname>Dopazo</surname>
								<given-names>J</given-names>
							</name>
							</person-group>
							<year>2005</year>
							<article-title>BABELOMICS: a suite of web tools for functional annotation and analysis of groups of genes in high-throughput experiments</article-title>
							<source>Nucleic Acids Res</source>
							<volume>33</volume>
							<fpage>W460</fpage>
							<lpage>464</lpage>
					</citation>
					</ref>
					<ref id="r3">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Chi</surname>
								<given-names>A</given-names>
							</name>
							<name>
								<surname>Valencia</surname>
								<given-names>JC</given-names>
							</name>
							<name>
								<surname>Hu</surname>
								<given-names>ZZ</given-names>
							</name>
							<name>
								<surname>Watabe</surname>
								<given-names>H</given-names>
							</name>
							<name>
								<surname>Yamaguchi</surname>
								<given-names>H</given-names>
							</name><etal/>
							</person-group>
							<year>2006</year>
							<article-title>Proteomic and bioinformatic characterization of the biogenesis and function of  melanosomes</article-title>
							<source>J Proteome Res</source>
							<volume>5</volume>
							<fpage>3135</fpage>
							<lpage>3144</lpage>
					</citation>
					</ref>
					<ref id="r4">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Duxbury</surname>
								<given-names>MS</given-names>
							</name>
							<name>
								<surname>Ito</surname>
								<given-names>H</given-names>
							</name>
							<name>
								<surname>Zinner</surname>
								<given-names>MJ</given-names>
							</name>
							<name>
								<surname>Ashley</surname>
								<given-names>SW</given-names>
							</name>
							<name>
								<surname>Whang</surname>
								<given-names>EE</given-names>
							</name>
							</person-group>
							<year>2007</year>
							<article-title>RNA interference targeting the M2 subunit of ribonucleotide reductase enhances        pancreatic adenocarcinoma chemosensitivity to gemcitabine</article-title>
							<source>Oncogene</source>
							<volume>23</volume>
							<fpage>1539</fpage>
							<lpage>1548</lpage>
					</citation>
					</ref>
					<ref id="r5">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Ekins</surname>
								<given-names>S</given-names>
							</name>
							<name>
								<surname>Nikolsky</surname>
								<given-names>Y</given-names>
							</name>
							<name>
								<surname>Bugrim</surname>
								<given-names>A</given-names>
							</name>
							<name>
								<surname>Kirillov</surname>
								<given-names>E</given-names>
							</name>
							<name>
								<surname>Nikolskaya</surname>
								<given-names>T</given-names>
							</name>
							</person-group>
							<year>2007</year>
							<article-title>Pathway mapping tools for analysis of high content data</article-title>
							<source>Methods Mol Biol</source>
							<volume>356</volume>
							<fpage>319</fpage>
							<lpage>350</lpage>
					</citation>
					</ref>
					<ref id="r6">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Hewick</surname>
								<given-names>RM</given-names>
							</name>
							<name>
								<surname>Lu</surname>
								<given-names>Z</given-names>
							</name>
							<name>
								<surname>Wang</surname>
								<given-names>JH</given-names>
							</name>
							</person-group>
							<year>2003</year>
							<article-title>Proteomics in drug discovery</article-title>
							<source>Adv Protein Chem</source>
							<volume>65</volume>
							<fpage>309</fpage>
							<lpage>342</lpage>
					</citation>
					</ref>
					<ref id="r7">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Hu</surname>
								<given-names>ZZ</given-names>
							</name>
							<name>
								<surname>Valencia</surname>
								<given-names>JC</given-names>
							</name>
							<name>
								<surname>Huang</surname>
								<given-names>H</given-names>
							</name>
							<name>
								<surname>Chi</surname>
								<given-names>A</given-names>
							</name>
							<name>
								<surname>Shabanowitz</surname>
								<given-names>J</given-names>
							</name><etal/>
							</person-group>
							<year>2007</year>
							<article-title>Comparative Bioinformatics Analyses and Profiling of Lysosome-Related Organelle    Proteomes</article-title>
							<source>Int J Mass Spectrom</source>
							<volume>259</volume>
							<fpage>147</fpage>
							<lpage>160</lpage>
					</citation>
					</ref>
					<ref id="r8">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Huang</surname>
								<given-names>H</given-names>
							</name>
							<name>
								<surname>Hu</surname>
								<given-names>ZZ</given-names>
							</name>
							<name>
								<surname>Arighi</surname>
								<given-names>CN</given-names>
							</name>
							<name>
								<surname>Wu</surname>
								<given-names>CH</given-names>
							</name>
							</person-group>
							<year>2007</year>
							<article-title>Integration of bioinformatics resources for functional analysis of gene expression   and proteomic data</article-title>
							<source>Front Biosci.</source>
							<volume>12</volume>
							<fpage>5071</fpage>
							<lpage>5088</lpage>
					</citation>
					</ref>
					<ref id="r9">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Huang da</surname>
								<given-names>W</given-names>
							</name>
							<name>
								<surname>Sherman</surname>
								<given-names>BT</given-names>
							</name>
							<name>
								<surname>Tan</surname>
								<given-names>Q</given-names>
							</name>
							<name>
								<surname>Kir</surname>
								<given-names>J</given-names>
							</name>
							<name>
								<surname>Liu</surname>
								<given-names>D</given-names>
							</name><etal/>
							</person-group>
							<year>2007</year>
							<article-title>DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to  better extract biology from large gene lists</article-title>
							<source>Nucleic Acids Res</source>
							<volume>35</volume>
							<fpage>W169</fpage>
							<lpage>W175</lpage>
					</citation>
					</ref>
					<ref id="r10">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Jansen</surname>
								<given-names>RC</given-names>
							</name>
							<name>
								<surname>Nap</surname>
								<given-names>JP</given-names>
							</name>
							<name>
								<surname>Mlynarova</surname>
								<given-names>L</given-names>
							</name>
							</person-group>
							<year>2002</year>
							<article-title>Errors in genomics and proteomics</article-title>
							<source>Nat Biotechnol</source>
							<volume>20</volume>
							<fpage>19</fpage>
					</citation>
					</ref>
					<ref id="r11">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Jeggo</surname>
								<given-names>PA</given-names>
							</name>
							<name>
								<surname>Lobrich</surname>
								<given-names>M</given-names>
							</name>
							</person-group>
							<year>2006</year>
							<article-title>Contribution of DNA repair and cell cycle checkpoint arrest to the maintenance of   genomic stability</article-title>
							<source>DNA Repair (Amst)</source>
							<volume>5</volume>
							<fpage>1192</fpage>
							<lpage>1198</lpage>
					</citation>
					</ref>
					<ref id="r12">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Jung</surname>
								<given-names>M</given-names>
							</name>
							<name>
								<surname>Zhang</surname>
								<given-names>Y</given-names>
							</name>
							<name>
								<surname>Lee</surname>
								<given-names>S</given-names>
							</name>
							<name>
								<surname>Dritschilo</surname>
								<given-names>A</given-names>
							</name>
							</person-group>
							<year>1995</year>
							<article-title>Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated I kappa B-alpha</article-title>
							<source>Science</source>
							<volume>268</volume>
							<fpage>1619</fpage>
							<lpage>1621</lpage>
					</citation>
					</ref>
					<ref id="r13">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Jung</surname>
								<given-names>M</given-names>
							</name>
							<name>
								<surname>Dritschilo</surname>
								<given-names>A</given-names>
							</name>
							</person-group>
							<year>2001</year>
							<article-title>NF-kappa B signaling pathway as a target for human tumor radiosensitization</article-title>
							<source>Semin Radiat Oncol</source>
							<volume>11</volume>
							<fpage>346</fpage>
							<lpage>351</lpage>
					</citation>
					</ref>
					<ref id="r14">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Kastan</surname>
								<given-names>MB</given-names>
							</name>
							<name>
								<surname>Lim</surname>
								<given-names>DS</given-names>
							</name>
							<name>
								<surname>Kim</surname>
								<given-names>ST</given-names>
							</name>
							<name>
								<surname>Yang</surname>
								<given-names>D</given-names>
							</name>
							</person-group>
							<year>2001</year>
							<article-title>ATM—a key determinant of multiple cellular responses to irradiation</article-title>
							<source>Acta Oncol</source>
							<volume>40</volume>
							<fpage>686</fpage>
							<lpage>688</lpage>
					</citation>
					</ref>
					<ref id="r15">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Kim</surname>
								<given-names>GD</given-names>
							</name>
							<name>
								<surname>Choi</surname>
								<given-names>YH</given-names>
							</name>
							<name>
								<surname>Dimtchev</surname>
								<given-names>A</given-names>
							</name>
							<name>
								<surname>Jeong</surname>
								<given-names>SJ</given-names>
							</name>
							<name>
								<surname>Dritschilo</surname>
								<given-names>A</given-names>
							</name><etal/>
							</person-group>
							<year>1999</year>
							<article-title>Sensing of ionizing radiation-induced DNA damage by ATM through interaction with histone deacetylase</article-title>
							<source>J Biol Chem</source>
							<volume>274</volume>
							<fpage>31127</fpage>
							<lpage>31130</lpage>
					</citation>
					</ref>
					<ref id="r16">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Kuo</surname>
								<given-names>ML</given-names>
							</name>
							<name>
								<surname>Hwang</surname>
								<given-names>HS</given-names>
							</name>
							<name>
								<surname>Sosnay</surname>
								<given-names>PR</given-names>
							</name>
							<name>
								<surname>Kunugi</surname>
								<given-names>KA</given-names>
							</name>
							<name>
								<surname>Kinsella</surname>
								<given-names>TJ</given-names>
							</name>
							</person-group>
							<year>2003</year>
							<article-title>Overexpression of the R2 subunit of ribonucleotide reductase in human nasopharyngeal cancer cells reduces radiosensitivity</article-title>
							<source>Cancer J</source>
							<volume>9</volume>
							<fpage>277</fpage>
							<lpage>285</lpage>
					</citation>
					</ref>
					<ref id="r17">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Kurz</surname>
								<given-names>EU</given-names>
							</name>
							<name>
								<surname>Lees Miller</surname>
								<given-names>SP</given-names>
							</name>
							</person-group>
							<year>2004</year>
							<article-title>DNA damage-induced activation of ATM and ATM-dependent signaling pathways</article-title>
							<source>DNA Repair (Amst)</source>
							<volume>3</volume>
							<fpage>889</fpage>
							<lpage>900</lpage>
					</citation>
					</ref>
					<ref id="r18">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Lee</surname>
								<given-names>SA</given-names>
							</name>
							<name>
								<surname>Dritschilo</surname>
								<given-names>A</given-names>
							</name>
							<name>
								<surname>Jung</surname>
								<given-names>M</given-names>
							</name>
							</person-group>
							<year>2001</year>
							<article-title>Role of ATM in oxidative stress-mediated c-Jun phosphorylation in response to        ionizing radiation and CdCl2</article-title>
							<source>J Biol Chem</source>
							<volume>276</volume>
							<fpage>11783</fpage>
							<lpage>11790</lpage>
					</citation>
					</ref>
					<ref id="r19">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Li</surname>
								<given-names>W</given-names>
							</name>
							<name>
								<surname>Amri</surname>
								<given-names>H</given-names>
							</name>
							<name>
								<surname>Huang</surname>
								<given-names>H</given-names>
							</name>
							<name>
								<surname>Wu</surname>
								<given-names>C</given-names>
							</name>
							<name>
								<surname>Papadopoulos</surname>
								<given-names>V</given-names>
							</name>
							</person-group>
							<year>2004</year>
							<article-title>Gene and protein profiling of the response of MA-10 Leydig tumor cells to human       chorionic gonadotropin</article-title>
							<source>J Androl</source>
							<volume>25</volume>
							<fpage>900</fpage>
							<lpage>913</lpage>
					</citation>
					</ref>
					<ref id="r20">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Von Mering</surname>
								<given-names>C</given-names>
							</name>
							<name>
								<surname>Bork</surname>
								<given-names>P</given-names>
							</name>
							</person-group>
							<year>2002</year>
							<article-title>Teamed up for transcription</article-title>
							<source>Nature</source>
							<volume>417</volume>
							<fpage>797</fpage>
							<lpage>798</lpage>
					</citation>
					</ref>
					<ref id="r21">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Mewani</surname>
								<given-names>RR</given-names>
							</name>
							<name>
								<surname>Tian</surname>
								<given-names>S</given-names>
							</name>
							<name>
								<surname>Li</surname>
								<given-names>B</given-names>
							</name>
							<name>
								<surname>Danner</surname>
								<given-names>MT</given-names>
							</name>
							<name>
								<surname>Carr</surname>
								<given-names>TD</given-names>
							</name><etal/>
							</person-group>
							<year>2006</year>
							<article-title>Gene expression profile by inhibiting Raf-1 protein kinase in breast cancer cells</article-title>
							<source>Int J Mol Med</source>
							<volume>17</volume>
							<fpage>457</fpage>
							<lpage>463</lpage>
					</citation>
					</ref>
					<ref id="r22">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Perco</surname>
								<given-names>P</given-names>
							</name>
							<name>
								<surname>Kainz</surname>
								<given-names>A</given-names>
							</name>
							<name>
								<surname>Mayer</surname>
								<given-names>G</given-names>
							</name>
							<name>
								<surname>Lukas</surname>
								<given-names>A</given-names>
							</name>
							<name>
								<surname>Oberbauer</surname>
								<given-names>R</given-names>
							</name><etal/>
							</person-group>
							<year>2005</year>
							<article-title>Detection of coregulation in differential gene expression profiles</article-title>
							<source>Biosystems</source>
							<volume>82</volume>
							<fpage>235</fpage>
							<lpage>247</lpage>
					</citation>
					</ref>
					<ref id="r23">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Sarkaria</surname>
								<given-names>JN</given-names>
							</name>
							<name>
								<surname>Eshleman</surname>
								<given-names>JS</given-names>
							</name>
							</person-group>
							<year>2001</year>
							<article-title>ATM as a target for novel radiosensitizers</article-title>
							<source>Semin Radiat Oncol</source>
							<volume>11</volume>
							<fpage>316</fpage>
							<lpage>327</lpage>
					</citation>
					</ref>
					<ref id="r24">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Savitsky</surname>
								<given-names>K</given-names>
							</name>
							<name>
								<surname>Bar-Shira</surname>
								<given-names>A</given-names>
							</name>
							<name>
								<surname>Gilad</surname>
								<given-names>S</given-names>
							</name>
							<name>
								<surname>Rotman</surname>
								<given-names>G</given-names>
							</name>
							<name>
								<surname>Ziv</surname>
								<given-names>Y</given-names>
							</name><etal/>
							</person-group>
							<year>1995</year>
							<article-title>A single ataxia telangiectasia gene with a product similar to PI-3 kinase</article-title>
							<source>Science</source>
							<volume>268</volume>
							<fpage>1749</fpage>
							<lpage>1753</lpage>
					</citation>
					</ref>
					<ref id="r25">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Spitz</surname>
								<given-names>DR</given-names>
							</name>
							<name>
								<surname>Azzam</surname>
								<given-names>EI</given-names>
							</name>
							<name>
								<surname>Li</surname>
								<given-names>JJ</given-names>
							</name>
							<name>
								<surname>Gius</surname>
								<given-names>D</given-names>
							</name>
							</person-group>
							<year>2004</year>
							<article-title>Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: a unifying concept in stress response biology</article-title>
							<source>Cancer Metastasis Rev</source>
							<volume>23</volume>
							<fpage>311</fpage>
							<lpage>322</lpage>
					</citation>
					</ref>					
					<ref id="r26">
						<citation citation-type="patent">
						<collab collab-type="assignee">Uniprot C</collab>
						<article-title>The Universal Protein Resource (UniProt)</article-title>
						<source>Nucleic Acids Res</source>
						<year>2008</year>
						<volume>36</volume>
						<fpage>D190</fpage>
						<lpage>195</lpage>
				</citation>
			</ref>
					<ref id="r27">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Valerie</surname>
								<given-names>K</given-names>
							</name>
							<name>
								<surname>Yacoub</surname>
								<given-names>A</given-names>
							</name>
							<name>
								<surname>Hagan</surname>
								<given-names>MP</given-names>
							</name>
							<name>
								<surname>Curiel</surname>
								<given-names>DT</given-names>
							</name>
							<name>
								<surname>Fisher</surname>
								<given-names>PB</given-names>
							</name><etal/>
							</person-group>
							<year>2007</year>
							<article-title>Radiation-induced cell signaling: insideout and outside-in</article-title>
							<source>Mol Cancer Ther</source>
							<volume>6</volume>
							<fpage>789</fpage>
							<lpage>801</lpage>
					</citation>
					</ref>
					<ref id="r28">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Wu</surname>
								<given-names>CH</given-names>
							</name>
							<name>
								<surname>Huang</surname>
								<given-names>H</given-names>
							</name>
							<name>
								<surname>Nikolskaya</surname>
								<given-names>A</given-names>
							</name>
							<name>
								<surname>Hu</surname>
								<given-names>Z</given-names>
							</name>
							<name>
								<surname>Barker</surname>
								<given-names>WC</given-names>
							</name>
							</person-group>
							<year>2004</year>
							<article-title>The iProClass integrated database for protein functional analysis</article-title>
							<source>Comput Biol Chem</source>
							<volume>28</volume>
							<fpage>87</fpage>
							<lpage>96</lpage>
					</citation>
					</ref>
					<ref id="r29">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Xue</surname>
								<given-names>L</given-names>
							</name>
							<name>
								<surname>Zhou</surname>
								<given-names>B</given-names>
							</name>
							<name>
								<surname>Liu</surname>
								<given-names>X</given-names>
							</name>
							<name>
								<surname>Qiu</surname>
								<given-names>W</given-names>
							</name>
							<name>
								<surname>Jin</surname>
								<given-names>Z</given-names>
							</name><etal/>
							</person-group>
							<year>2003</year>
							<article-title>Wildtype p53 regulates human ribonucleotide reductase by protein- protein interaction  with p53R2 as well as hRRM2 subunits</article-title>
							<source>Cancer Res</source>
							<volume>63</volume>
							<fpage>980</fpage>
							<lpage>986</lpage>
					</citation>
					</ref>
					<ref id="r30">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Yanamoto</surname>
								<given-names>S</given-names>
							</name>
							<name>
								<surname>Iwamoto</surname>
								<given-names>T</given-names>
							</name>
							<name>
								<surname>Kawasaki</surname>
								<given-names>G</given-names>
							</name>
							<name>
								<surname>Yoshitomi</surname>
								<given-names>I</given-names>
							</name>
							<name>
								<surname>Baba</surname>
								<given-names>N</given-names>
							</name><etal/>
							</person-group>
							<year>2004</year>
							<article-title>Silencing of the p53R2 gene by RNA interference inhibits growth and enhances    5-fluorouracil sensitivity of oral cancer cells</article-title>
							<source>Cancer Lett</source>
							<volume>223</volume>
							<fpage>67</fpage>
							<lpage>76</lpage>
					</citation>
					</ref>
					<ref id="r31">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Yoon</surname>
								<given-names>JH</given-names>
							</name>
							<name>
								<surname>Singh</surname>
								<given-names>P</given-names>
							</name>
							<name>
								<surname>Lee</surname>
								<given-names>DH</given-names>
							</name>
							<name>
								<surname>Qiu</surname>
								<given-names>J</given-names>
							</name>
							<name>
								<surname>Cai</surname>
								<given-names>S</given-names>
							</name><etal/>
							</person-group>
							<year>2005</year>
							<article-title>Characterization of the 3' —> 5' exonuclease activity found in human nucleoside   diphosphate kinase 1 (NDK1) and several of its homologues</article-title>
							<source>Biochemistry</source>
							<volume>44</volume>
							<fpage>15774</fpage>
							<lpage>15786</lpage>
					</citation>
					</ref>
					<ref id="r32">
					<citation citation-type="journal">
							<person-group>
							<name>
								<surname>Zhou</surname>
								<given-names>B</given-names>
							</name>
							<name>
								<surname>Liu</surname>
								<given-names>X</given-names>
							</name>
							<name>
								<surname>Mo</surname>
								<given-names>X</given-names>
							</name>
							<name>
								<surname>Xue</surname>
								<given-names>L</given-names>
							</name>
							<name>
								<surname>Darwish</surname>
								<given-names>D</given-names>
							</name><etal/>
							</person-group>
							<year>2003</year>
							<article-title>The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53</article-title>
							<source>Cancer Res</source>
							<volume>63</volume>
							<fpage>6583</fpage>
							<lpage>6594</lpage>
					</citation>
					</ref>
             </ref-list>
		<glossary>
			<def-list>
				<title>Abbreviations</title>
				<def-item>
					<term>ATM</term>
					<def>
						<p>ataxia - teleangiectasis mutated</p>
					</def>
				</def-item>
				<def-item>
					<term>RRM2</term>
					<def>
						<p>ribonucleotide reductase subunit M2</p>
					</def>
				</def-item>
				<def-item>
					<term>GO</term>
					<def>
						<p>Gene Ontology</p>
					</def>
				</def-item>
				<def-item>
					<term>KEGG</term>
					<def>
						<p>Kyoto Encyclopedia of Genes and Genomes</p>
					</def>
				</def-item>
				<def-item>
					<term>iProXpress</term>
					<def>
						<p>integrated Protein eXpression system</p>
					</def>
				</def-item>
				<def-item>
					<term>UniProt</term>
					<def>
						<p>Unified Protein Resource</p>
					</def>
				</def-item>
				<def-item>
					<term>2D-gel/ MS</term>
					<def>
						<p>two-dimensional gel/mass spectrometry</p>
					</def>
				</def-item>
				<def-item>
					<term>PIR</term>
					<def>
						<p>Protein Information Resource</p>
					</def>
				</def-item>
			</def-list>
		</glossary>
	</back>
	 <floats-wrap >
	<table-wrap position="float" id="t1">
	<label>Table 1.</label>
  			<caption>
  				<title>Number of differentially expressed proteins or genes from irradiated AT5BIVA and ATCL8 cells</title>
  			</caption>
   <table frame="hsides" rules="groups">
      <thead>
  <tr>
    <th align="left"></th>
    <th align="left"></th>
    <th colspan="3" align="left">AT5BIVA</th>
    <th colspan="3" align="left">ATCL8</th>
  </tr>
      </thead>
      <tbody>
         <tr>
            <td></td>
   			<td>Time</td>
    		<td>up</td>
   			<td>down</td>
    		<td>change</td>
   			<td>up</td>
    		<td>down</td>
    		<td>change</td>		
         </tr>
         <tr>
            <td rowspan="5">2D-Gel/MALDI-MS</td>
   			<td>30min</td>
    		<td>12</td>
   			<td>43</td>
    		<td>*53</td>
    		<td>33</td>
   			<td>215</td>
    		<td>248</td>			
         </tr>
         <tr>
            <td>1hr</td>
    		<td>55</td>
    		<td>22</td>
    		<td>74</td>
   			<td>84</td>
    		<td>109</td>
    		<td>192</td>			
         </tr>
         <tr>
            <td>3hr</td>
    		<td>108</td>
    		<td>37</td>
    		<td>137</td>
    		<td>254</td>
    		<td>171</td>
    		<td>420</td>		
         </tr>
		 <tr>
            <td>24hr</td>
    		<td>66</td>
    		<td>156</td>
    		<td>214</td>
    		<td>20</td>
    		<td>190</td>
    		<td>210</td>		
         </tr>
		 <tr>
    		<td>Total</td>
    		<td>228</td>
    		<td>216</td>
    		<td>412</td>
    		<td>358</td>
    		<td>475</td>
    		<td>771</td>
  		</tr>
		<tr>
    <td rowspan="4">DNA Microarray</td>
    <td>30min</td>
    <td>11</td>
    <td>9</td>
    <td>20</td>
    <td>33</td>
    <td>22</td>
    <td>55</td>
  </tr>
  <tr>
    <td>1hr</td>
    <td>36</td>
    <td>28</td>
    <td>64</td>
    <td>10</td>
    <td>16</td>
    <td>26</td>
  </tr>
  <tr>
    <td>3hr</td>
    <td>20</td>
    <td>15</td>
    <td>35</td>
    <td>19</td>
    <td>47</td>
    <td>66</td>
  </tr>
  <tr>
    <td>Total</td>
    <td>57</td>
    <td>47</td>
    <td>103</td>
    <td>54</td>
    <td>77</td>
    <td>131</td>
  </tr>
     </tbody>
 	  </table>
	   <table-wrap-foot>
  				<fn>
  					<p>( &ast;) In some cases, the same protein was identified from different gel spots with one increased and
the other decreased in spot intensity. In such cases, the number of proteins in the “change” column will be less than the addition of those in “up” and “down” groups. For example, phosphoglycerate mutase 1 (UniProtKB: P18669) was identified form two gel spots, one appeared only in radiation treated AT5BIVA cells at 30min, and the other was in control cells only.</p>
  				</fn>
  			</table-wrap-foot>
 	</table-wrap>
	<table-wrap position="float" id="t2">
	<label>Table 2.</label>
  			<caption>
  				<title>Top categories of Gene Ontology (GO) and pathway profiles of proteomics data from irradiated AT5BIVA
and ATCL8 cells.</title>
  			</caption>
   <table frame="hsides" rules="groups">
      <thead>
         <tr>
    		<th align="left"></th>
    		<th align="left">AT5BIVA</th>
    		<th align="left">ATCL8</th>
  </tr>
      </thead>
      <tbody>
         <tr>
            <td></td>
    		<td colspan="2">up</td>
    		<td colspan="2">down</td>
    		<td>change</td>
    		<td colspan="2">up</td>
    		<td colspan="2">down</td>
    		<td>change</td>		
         </tr>
         <tr>
            <td>GO biological process</td>
    		<td>No.</td>
    		<td>%</td>
    		<td>No.</td>
    		<td>%</td>
    		<td>%</td>
    		<td>No.</td>
    		<td>%</td>
    		<td>No.</td>
    		<td>%</td>
    		<td>%</td>	
         </tr>
         <tr>
            <td>RNA metabolism</td>
    		<td>36</td>
    		<td>15.8</td>
    		<td>25</td>
    		<td>11.6</td>
    		<td>14.8</td>
    		<td>57</td>
    		<td>15.9</td>
    		<td>82</td>
    		<td>17.3</td>
    		<td>18.0</td>			
         </tr>
         <tr>
            <td>signal transduction</td>
    		<td>32</td>
    		<td>14.0</td>
   			<td>33</td>
    		<td>15.3</td>
    		<td>15.8</td>
    		<td>54</td>
    		<td>15.1</td>
    		<td>61</td>
    		<td>12.8</td>
    		<td>14.9</td>		
         </tr>
		 <tr>
            <td>transcription</td>
    	    <td>35</td>
    	    <td>15.4</td>
    	    <td>25</td>
    		<td>11.6</td>
    		<td>14.6</td>
   			<td>55</td>
    		<td>15.4</td>
    		<td>83</td>
    		<td>17.5</td>
    		<td>17.9</td>			
         </tr>
		 <tr>
            <td>protein modification</td>
    		<td>27</td>
    		<td>11.8</td>
    		<td>19</td>
    		<td>8.8</td>
    		<td>11.2</td>
    		<td>48</td>
    		<td>13.4</td>
    		<td>37</td>
    		<td>7.8</td>
    		<td>11.0</td>			
         </tr>
		 <tr>
            <td>generation of precursor metabolites and energy</td>
    		<td>16</td>
    		<td>7.0</td>
    		<td>12</td>
    		<td>5.6</td>
    		<td>6.8</td>
    		<td>15</td>
    		<td>4.2</td>
    		<td>21</td>
    		<td>4.4</td>
    		<td>4.7</td>		
         </tr>
		 <tr>
    		<td>phosphorus metabolism</td>
    		<td>14</td>
    		<td>6.1</td>
    		<td>8</td>
    		<td>3.7</td>
    		<td>5.3</td>
    		<td>29</td>
    		<td>8.1</td>
    		<td>20</td>
    		<td>4.2</td>
    		<td>6.4</td>
  		</tr>
		<tr>
    		<td>protein biosynthesis</td>
    		<td>13</td>
    		<td>5.7</td>
    		<td>3</td>
    		<td>1.4</td>
    		<td>3.9</td>
    		<td>8</td>
    		<td>2.2</td>
    		<td>16</td>
    		<td>3.4</td>
    		<td>3.1</td>
 		 </tr>
		 <tr>
    		<td>cell cycle</td>
    		<td>11</td>
    		<td>4.8</td>
    		<td>18</td>
    		<td>8.3</td>
    		<td>7.0</td>
    		<td>22</td>
    		<td>6.1</td>
    		<td>26</td>
    		<td>5.5</td>
    		<td>6.2</td>
  		</tr>		
  		<tr>
    		<td>KEGG Pathway</td>
    		<td></td>
    		<td></td>
    		<td></td>
    		<td></td>
    		<td></td>
    		<td></td>
    		<td></td>
    		<td></td>
    		<td></td>
    		<td></td>
  		</tr>
  		<tr>
    		<td>purine metabolism</td>
    		<td>3</td>
    		<td>1.3</td>
    		<td>8</td>
    		<td>3.7</td>
    		<td>2.7</td>
    		<td>5</td>
    		<td>1.4</td>
    		<td>8</td>
    		<td>1.7</td>
    		<td>1.7</td>
  		</tr>
  		<tr>
    		<td>glycolysis/gluconeogenesis</td>
    		<td>5</td>
    		<td>2.2</td>
    		<td>5</td>
    		<td>2.3</td>
    		<td>2.4</td>
    		<td>2</td>
    		<td>0.6</td>
    		<td>5</td>
    		<td>1.1</td>
    		<td>0.9</td>
  		</tr>
  		<tr>
    		<td>pyrimidine metabolism</td>
    		<td>1</td>
    		<td>0.4</td>
    		<td>4</td>
    		<td>1.9</td>
    		<td>1.2</td>
    		<td>2</td>
    		<td>0.6</td>
    		<td>4</td>
    		<td>0.8</td>
    		<td>0.8</td>
  		</tr>
  		<tr>
    		<td>fructose and mannose metabolism</td>
    		<td>2</td>
    		<td>0.9</td>
    		<td>1</td>
    		<td>0.5</td>
    		<td>0.7</td>
    		<td>3</td>
    		<td>0.8</td>
    		<td>2</td>
    		<td>0.4</td>
    		<td>0.6</td>
  		</tr>
  		<tr>
    		<td>glutamate metabolism</td>
    		<td>3</td>
    		<td>1.3</td>
    		<td>1</td>
    		<td>0.5</td>
    		<td>1.0</td>
    		<td>1</td>
    		<td>0.3</td>
    		<td>1</td>
    		<td>0.2</td>
    		<td>0.3</td>
  		</tr>
  		<tr>
    		<td>starch and sucrose metabolism</td>
    		<td>4</td>
    		<td>1.8</td>
    		<td>1</td>
    		<td>0.5</td>
    		<td>1.2</td>
    		<td>5</td>
    		<td>1.4</td>
    		<td>7</td>
    		<td>1.5</td>
    		<td>1.6</td>
  		</tr>
  		<tr>
    		<td>butanoate metabolism</td>
    		<td>-</td>
    		<td></td>
    		<td>2</td>
    		<td>0.9</td>
    		<td>0.0</td>
    		<td>4</td>
    		<td>1.1</td>
    		<td>2</td>
    		<td>0.4</td>
   			<td>0.8</td>
  		</tr>
  		<tr>
    		<td>folate biosynthesis</td>
    		<td>4</td>
    		<td>1.8</td>
			<td>1</td>
    		<td>0.5</td>
    		<td>1.2</td>
    		<td>4</td>
    		<td>1.1</td>
    		<td>4</td>
    		<td>0.8</td>
    		<td>1.0</td>
  		</tr>
  		<tr>
    		<td>pyruvate metabolism</td>
    		<td>-</td>
    		<td></td>
    		<td>3</td>
    		<td>1.4</td>
    		<td>0.0</td>
    		<td>2</td>
    		<td>0.6</td>
    		<td>1</td>
    		<td>0.2</td>
    		<td>0.4</td>
  		</tr>
  		<tr>
    		<td>cell cycle</td>
    		<td>2</td>
    		<td>0.9</td>
    		<td>5</td>
    		<td>2.3</td>
    		<td>1.7</td>
    		<td>6</td>
    		<td>1.7</td>
    		<td>6</td>
    		<td>1.3</td>
    		<td>1.6</td>
  		</tr>
  		<tr>
    		<td>total # unique proteins</td>
    		<td>228</td>
    		<td>-</td>
    		<td>216</td>
    		<td>-</td>
    		<td>412</td>
			<td>358</td>
    		<td>-</td>
    		<td>475</td>
    		<td>-</td>
    		<td>771</td>
  		</tr>
     </tbody>
 	</table>
	  <table-wrap-foot>
  				<fn>
  					<p>The number of proteins (under No. column) is shown for profiles based on up-, down-regulated proteins in the two cell types. Numbers in bold face are for top 5 categories of GO or KEGG pathways for the given data group (up or down). Numbers under percentage (%) column show the percentage of changed proteins compared to total protein changes (shown at the bottom row, total # unique proteins) in given data groups (up, down, or combined as “change”). The complete profiles can be dynamically generated from the iProXpress website.</p>
  				</fn>
  			</table-wrap-foot>
 	</table-wrap>
	
	<table-wrap position="float" id="t3">
	<label>Table 3.</label>
  			<caption>
  				<title>Differentially expressed proteins in purine metabolism in AT5BIVA and ATCL8 cells after irradiation.</title>
  			</caption>
   <table frame="hsides" rules="groups">
      <thead>
         <tr>
            <th align="left">Time</th>
    		<th align="left" colspan="3">AT5BIVA</th>
    		<th align="left" colspan="3">ATCL8</th>			
         </tr>
		 <tr>
    		<th align="left">UniProt*</th>
    		<th align="left">Protein name</th>
    		<th align="left">Change</th>
    		<th align="left">UniProt</th>
    		<th align="left">Protein name</th>
    		<th align="left">Change</th>
  		</tr>
      </thead>
      <tbody>
         <tr>
            <td rowspan="4">30min</td>
    		<td rowspan="2">P54819</td>
    		<td rowspan="2">Adenylate kinase isoenzyme 2, mitochondrial [2.7.4.3]</td>
    		<td rowspan="2">down</td>
    		<td>P54819</td>
    		<td>Adenylate kinase isoenzyme 2, mitochondrial [2.7.4.3]</td>
    		<td>up</td>		
         </tr>
         <tr>
            <td>Q07343</td>
    		<td>cAMP-specific 3',5'-cyclic phosphodiesterase 4B [3.1.4.17]</td>
    		<td>down</td>			
         </tr>
         <tr>
            <td rowspan="2">Q15054</td>
    		<td rowspan="2">DNA polymerase subunit delta 3 [2.7.7.7]</td>
    		<td rowspan="2">down</td>
    		<td>O15067</td>
    		<td>Phosphoribosylformylglycinamidine synthase [6.3.5.3]</td>
    		<td>down</td>			
         </tr>
         <tr>
            <td>P00492</td>
    		<td>Hypoxanthine-guanine phosphoribosyltransferase [2.4.2.8]</td>
    		<td>down</td>	
         </tr>
		 <tr>
            <td rowspan="3">1hr</td>
    		<td rowspan="3">O75343</td>
    		<td rowspan="3">Guanylate cyclase soluble subunit beta-2 [4.6.1.2]</td>
    		<td rowspan="3">up</td>
    		<td>P31350</td>
    		<td>Ribonucleoside-diphosphate reductase M2 subunit [1.17.4.1]</td>
    		<td>up</td>		
         </tr>
		 <tr>
            <td>P22234</td>
    		<td>Multifunctional protein ADE2 [6.3.2.6; 4.1.1.21]</td>
    		<td>down</td>		
         </tr>
		 <tr>
            <td>Q07343</td>
    		<td>cAMP-specific 3',5'-cyclic phosphodiesterase 4B [3.1.4.17]</td>
    		<td>down</td>			
         </tr>
		 <tr>
    		<td rowspan="7">3hr**</td>
    		<td>P12268</td>
    		<td>Inosine-5'-monophosphate dehydrogenase 2 [1.1.1.205]</td>
    		<td>up</td>
    		<td>Q9Y2Y1(571)</td>
    		<td rowspan="2">DNA-directed RNA polymerase III subunit RPC10 [2.7.7.6]</td>
    		<td rowspan="2">up</td>
  		</tr>
  		<tr>
    		<td>Q9BW91</td>
    		<td>ADP-ribose pyrophosphatase, mitochondrial precursor [3.6.1.13]</td>
    		<td>up</td>
  		</tr>
  		<tr>
    		<td>P55263</td>
    		<td>Adenosine kinase [2.7.1.20]</td>
    		<td>down</td>
    		<td>P14618(1060)</td>
    		<td>Pyruvate kinase isozymes M1/M2 [2.7.1.40]</td>
    		<td>up</td>
  		</tr>
 		 <tr>
    		<td>P31939</td>
    		<td>Bifunctional purine biosynthesis protein PURH [2.1.2.3; 3.5.4.10]</td>
    		<td>down</td>
    		<td>P31350 (472)</td>
    		<td rowspan="2">Ribonucleoside-diphosphate reductase subunit M2 [1.17.4.1]</td>
    		<td rowspan="2">up</td>
  		</tr>
  		<tr>
    		<td>P22392</td>
    		<td>Nucleoside diphosphate kinase B [2.7.4.6]</td>
    		<td>down</td>
  		</tr>
  		<tr>
    		<td>P15531</td>
    		<td>Nucleoside diphosphate kinase A [2.7.4.6]</td>
    		<td>down</td>
    		<td rowspan="2">Q07343 (1060, 383, 472)</td>
    		<td rowspan="2">cAMP-specific 3',5'-cyclic phosphodiesterase 4B [3.1.4.17] (with several isoforms: PDE4B1, 2, 3)</td>
    		<td rowspan="2">up</td>
  		</tr>
  		<tr>
    		<td>O60361</td>
    		<td>Putative nucleoside diphosphate kinase [2.7.4.6]</td>
    		<td>down</td>
  		</tr>
  		<tr>
    		<td rowspan="3">24hr</td>
    		<td rowspan="3">O43306</td>
    		<td rowspan="3">Adenylate cyclase type 6 [4.6.1.1]</td>
    		<td rowspan="3">down</td>
    		<td>P12268</td>
    		<td>Inosine-5'-monophosphate dehydrogenase 2 [1.1.1.205]</td>
    		<td>down</td>
  		</tr>
  		<tr>
    		<td>P54819</td>
    		<td>Adenylate kinase isoenzyme 2, mitochondrial [2.7.4.3]</td>
    		<td>down</td>
  		</tr>
  		<tr>
    		<td>Q9Y2T3</td>
    		<td>Guanine deaminase [3.5.4.3]</td>
    		<td>down</td>
  		</tr>
     </tbody>
 	  </table>
	  <table-wrap-foot>
  				<fn>
  					<p>&ast; Proteins are given as UniProt Knowledgebase accession #; the enzyme commission numbers (EC#, e.g. 2.7.4.3) in brackets following protein names are functional classification of enzymes. Note, the enzyme “putative nucleoside diphosphate kinase, EC 2.7.4.6” (UniProt: O60361, 3hr in AT5BIVA), which has not been annotated for the purine metabolism
pathway in KEGG database, is included in the table.</p>
  				</fn>
  			</table-wrap-foot>
 	</table-wrap>	
	<table-wrap position="float" id="t4">
	<label>Table 4.</label>
  			<caption>
  				<title>Gene products with differential gene expression at 30min after irradiation in ATCL8 cells.</title>
  			</caption>
   <table frame="hsides" rules="groups">
      <thead>
         <tr>
            <th align="left">UniProt*</th>
            <th align="left">Protein Name</th>
            <th align="left">Change</th>
			<th align="left">GO Process**</th>					
         </tr>
      </thead>
      <tbody>
         <tr>
            <td>Q13283</td>
            <td>Ras GTPase-activating protein-binding protein 1 (EC 3.6.1.-) (G3BP-1)</td>
            <td>up</td>
			<td>signal transduction</td>            		
         </tr>
         <tr>
            <td>P48546</td>
            <td>Gastric inhibitory polypeptide receptor precursor (GIP-R)</td>
            <td>up</td>
			<td>signal transduction</td>            	
         </tr>
         <tr>
            <td>Q13442</td>
            <td>28 kDa heat- and acid-stable phosphoprotein (PDGF-associated protein) (PAP)</td>
            <td>up</td>
			<td>signal transduction</td>            	
         </tr>
         <tr>
            <td>Q13177</td>
            <td>Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (p21-activated kinase 2) (PAK-2)</td>
            <td>up</td>
			<td>signal transduction, protein modification</td>            	
         </tr>
		 <tr>
            <td>P28223</td>
            <td>5-hydroxytryptamine receptor 2A (5-HT-2A) (Serotonin receptor 2A) (5-HT-2)</td>
            <td>down</td>
			<td>signal transduction</td>            		
         </tr>
		 <tr>
            <td>Q15389</td>
            <td>Angiopoietin-1 precursor (ANG-1)</td>
            <td>down</td>
			<td>signal transduction</td>           	
         </tr>
		 <tr>
            <td>P32238</td>
            <td>Cholecystokinin receptor type A (CCK-A receptor) (CCK-AR) (CCK1-R)</td>
            <td>down</td>
			<td>signal transduction</td>            	
         </tr>
		 <tr>
            <td>P01236</td>
            <td>Prolactin precursor (PRL)</td>
            <td>down</td>
			<td>signal transduction</td>            	
         </tr>
		 <tr>
            <td>P49796</td>
            <td>Regulator of G-protein signaling 3 (RGS3) (RGP3)</td>
            <td>down</td>
			<td>signal transduction</td>            	
         </tr>
		 <tr>
            <td>P04637</td>
            <td>Cellular tumor antigen p53 (Tumor suppressor p53)</td>
            <td>up</td>
			<td>signal transduction, transcription, cell death</td>            	
         </tr>
		 <tr>
            <td>P38398</td>
            <td>Breast cancer type 1 susceptibility protein (RING finger protein 53)</td>
            <td>up</td>
			<td>transcription, protein modification, cell death</td>            	
         </tr>
		 <tr>
            <td>Q13547</td>
            <td>Histone deacetylase 1 (EC 3.5.1.98) (HD1)</td>
            <td>up</td>
			<td>transcription, protein modification, cell death</td>            	
         </tr>
		 <tr>
            <td>P40763</td>
            <td>Signal transducer and activator of transcription 3 (Acute-phase response factor)</td>
            <td>up</td>
			<td>signal transduction, transcription</td>            	
         </tr>
		 <tr>
            <td>P42226</td>
            <td>Signal transducer and activator of transcription 6 (IL-4 Stat)</td>
            <td>up</td>
			<td>signal transduction, transcription</td>            	
         </tr>
		 <tr>
            <td>Q15573</td>
            <td>TATA box-binding protein-associated factor RNA polymerase I subunit A (TAF1A)</td>
            <td>down</td>
			<td>transcription</td>            	
         </tr>
		 <tr>
            <td>P15622</td>
            <td>Zinc finger protein 250 (Zinc finger protein 647)</td>
            <td>down</td>
			<td>transcription</td>            	
         </tr>
		 <tr>
            <td>Q9UJL9</td>
            <td>Zinc finger protein 643</td>
            <td>down</td>
			<td>transcription</td>            	
         </tr>
		 <tr>
            <td>P14652</td>
            <td>Homeobox protein Hox-B2 (Hox-2H) (Hox-2.8) (K8)</td>
            <td>down</td>
			<td>transcription</td>            	
         </tr>
		 <tr>
            <td>O75752</td>
            <td>UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 1 (EC 2.4.1.79) (Beta-3-GalNAc-T1)</td>
            <td>up</td>
			<td>transcription</td>            	
         </tr>
		 <tr>
            <td>P23443</td>
            <td>Ribosomal protein S6 kinase beta-1 (EC 2.7.11.1) (S6K) (S6K1)</td>
            <td>up</td>
			<td>signal transduction, transcription</td>            	
         </tr>
		 <tr>
            <td>Q15119</td>
            <td>[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial precursor (EC 2.7.11.2)</td>
            <td>up</td>
			<td>transcription</td>            	
         </tr>
		 <tr>
            <td>Q9Y2K2</td>
            <td>Serine/threonine-protein kinase QSK (EC 2.7.11.1) (Salt-inducible kinase 3) (SIK-3)</td>
            <td>up</td>
			<td>transcription</td>            	
         </tr>
		 <tr>
            <td>Q10469</td>
            <td>Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.143)</td>
            <td>down</td>
			<td>transcription</td>            	
         </tr>
     </tbody>
 	  </table>
	  <table-wrap-foot>
  				<fn>
  					<p>&ast; Gene IDs (NCBI gi # or Entrez Gene #) from microarray data were mapped to UniProt Knowledgebase accession numbers.</p>
  				</fn>
  			</table-wrap-foot>
 	</table-wrap>
	<table-wrap position="float" id="t5">
	<label>Table 5.</label>
  			<caption>
  				<title>Common proteins identified from proteomics and microarray data of irradiated.</title>
  			</caption>
   <table frame="hsides" rules="groups">
      <thead>
         <tr>
            <th align="left">UniProt</th>
            <th align="left">Protein Name</th>
            <th align="left">Proteomics</th>
			<th align="left">Microarray</th>
			<th align="left">Note (KEGG Pathway)*</th>					
         </tr>
      </thead>
      <tbody>
         <tr>
            <td>O75752</td>
    		<td>UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 1 (EC 2.4.1.79)</td>
    		<td>3hr up</td>
    		<td>30min up</td>
    		<td>Glycosphingolipid biosynthesis Glycan structures-biosynthesis 2</td>          
         </tr>
         <tr>
            <td>P02786</td>
            <td>Transferrin receptor protein 1 (TfR1)</td>
            <td>3hr up</td>
			<td>3hr up</td>
            <td>Hematopoietic cell ineage</td>           		
         </tr>
         <tr>
            <td>P15621</td>
            <td>Zinc finger protein 44 (Zinc finger protein KOX7)</td>
            <td>1hr, 24hr down</td>
			<td>3hr down</td>
            <td></td>            
         </tr>
         <tr>
            <td>P15622</td>
            <td>Zinc finger protein 250 (Zinc finger protein 647)</td>
            <td>30min down 1hr, 3hr up</td>
			<td>30min down</td>
            <td></td>           	
         </tr>
		 <tr>
            <td>P31350</td>
            <td>Ribonucleoside-diphosphate reductase M2 subunit (EC 1.17.4.1)</td>
            <td>1hr, 3hr up</td>
			<td>30min up</td>
            <td>Purine metabolism; Pyrimidine metabolism; p53 signaling pathway</td>           		
         </tr>
		  <tr>
            <td>P40763</td>
            <td>Signal transducer and activator of transcription 3 (Stat3)</td>
            <td>3hr down</td>
			<td>30min up</td>
            <td>Adipocytokine signaling pathway; Jak-STAT signaling pathway; Pancreatic cancer</td>           		
         </tr>
		  <tr>
    		<td>Q02742</td>
    		<td>Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase</td>
    		<td>1hr, 24hr down</td>
    		<td>3hr down</td>
    		<td>Glycan structures -biosynthesis 1; O-Glycan biosynthesis</td>
  		</tr>
  		<tr>
    		<td>Q07343</td>
    		<td>cAMP-specific 3',5'-cyclic phosphodiesterase 4B (EC 3.1.4.17) DPDE4)</td>
    		<td>30min, 1hr down 3hr up</td>
    		<td>3hr down</td>
    		<td>Purine metabolism</td>
  		</tr>
  		<tr>
    		<td>Q15119</td>
    		<td>Pyruvate dehydrogenase kinase isoform 2</td>
    		<td>3hr up</td>
    		<td>30min up</td>
    		<td></td>
  		</tr>
  		<tr>
    		<td>Q86UE4</td>
    		<td>Protein LYRIC (Lysine-rich CEACAM1 co-isolated protein)</td>
    		<td>3hr down</td>
    		<td>30min up</td>
   			<td></td>
 		 </tr>
  		 <tr>
    		<td colspan="5">AT5BIVA</td>
  		</tr>
  		<tr>
    		<td>O94844</td>
    		<td>Rho-related BTB domain-containing protein 1</td>
    		<td>24hr up</td>
    		<td>3hr down</td>
    		<td></td>
  		</tr>
  		<tr>
   			<td>P11182</td>
    		<td>Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase</td>
    		<td>1hr up</td>
    		<td>1hr, 3hr down</td>
    		<td>Valine, leucine and isoleucine degradation</td>
  		</tr>
  		<tr>
    		<td>Q7Z6Z7</td>
    		<td>HECT, UBA and WWE domain-containing protein 1 (EC 6.3.2.-)</td>
    		<td>3hr up</td>
    		<td>1hr down</td>
    		<td>Ubiquitin mediated proteolysis</td>
  		</tr>
     </tbody>
 	  </table>
	  <table-wrap-foot>
  				<fn>
  					<p>&ast; Shown are only annotated canonical pathways for given proteins in the KEGG pathway database.</p>
  				</fn>
  			</table-wrap-foot>
 	</table-wrap>	
	</floats-wrap>
</article>
